In conclusion, there is a significant relationship between loss of E-cadherin expression and other known factors for poor prognosis in CMTs, such as tumor size, ulceration, histological type, type of growth, lymph node metastasis and necrosis [31,32,33]. Here, CDH1 is linked to metastatic malignant neoplasm in the lymph nodes.